Kadmon Holdings LLC (NASDAQ:KDMN) traded down 5.6% during trading on Wednesday . The stock traded as low as $7.51 and last traded at $7.60, with a volume of 65,581 shares traded. The stock had previously closed at $8.05.

Several equities research analysts have recently commented on the stock. JMP Securities assumed coverage on shares of Kadmon Holdings in a research report on Monday, August 22nd. They issued an “outperform” rating and a $16.00 target price for the company. Jefferies Group initiated coverage on shares of Kadmon Holdings in a research report on Monday, August 22nd. They issued a “buy” rating and a $12.00 target price for the company. HC Wainwright initiated coverage on shares of Kadmon Holdings in a research report on Monday, August 22nd. They set a “buy” rating and a $25.00 price target for the company. Citigroup Inc. initiated coverage on shares of Kadmon Holdings in a research report on Monday, August 22nd. They set a “neutral” rating and a $12.00 price target for the company. Finally, WBB Securities initiated coverage on shares of Kadmon Holdings in a research report on Monday, August 1st. They set a “sell” rating and a $7.50 price target for the company. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and three have assigned a buy rating to the stock. The company has an average rating of “Hold” and a consensus price target of $14.50.

The firm’s market capitalization is $356.57 million. The stock’s 50-day moving average price is $9.43 and its 200 day moving average price is $9.44.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/21/kadmon-holdings-llc-kdmn-trading-down-5-6.html

In other news, major shareholder Daniel S. Loeb acquired 1,431,996 shares of the business’s stock in a transaction on Wednesday, August 3rd. The shares were acquired at an average price of $11.35 per share, for a total transaction of $16,253,154.60. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, major shareholder Daniel S. Loeb acquired 66,828 shares of the business’s stock in a transaction on Friday, August 5th. The shares were purchased at an average price of $9.94 per share, for a total transaction of $664,270.32. The disclosure for this purchase can be found here.

About Kadmon Holdings

Kadmon Holdings, LLC is a biopharmaceutical company engaged in the discovery, development and commercialization of small molecules and biologics to address disease areas of unmet medical need. The Company is developing product candidates within autoimmune and fibrotic diseases, oncology and genetic diseases.

5 Day Chart for NASDAQ:KDMN

Receive News & Ratings for Kadmon Holdings LLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kadmon Holdings LLC and related companies with MarketBeat.com's FREE daily email newsletter.